Trials / Completed
CompletedNCT01077479
Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Western Sydney Local Health District · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to assess the efficacy of metformin in abrogating androgen deprivation therapy (ADT) induced insulin resistance as measured by homeostasis model assessment (HOMAIR) in men with non-metastatic prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | Metformin 1500mg nocte for 6 months |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2010-03-01
- Last updated
- 2014-05-15
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01077479. Inclusion in this directory is not an endorsement.